Abdolkarim Mahrooz
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 29, 2024
Unraveling the understudied influence of a lead variant in the 9p21 locus on the atherogenic index among type 2 diabetes patients with coronary artery disease.Mahsa Naserian, Ahad Alizadeh, Mani Nosrati
|Jun 27, 2024
Altered expression of miR-375 and miR-541 in type 2 diabetes patients with and without coronary artery disease (CAD): the potential of miR-375 as a CAD biomarker.Parisa Sangali, Sara Abdullahi, Mani Nosrati
|Sep 15, 2021
Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis.Anvarsadat Kianmehr, Durdi Qujeq, Abouzar Bagheri
|May 03, 2021
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications.Anvarsadat Kianmehr, Isabella Faraoni, Omer Kucuk
|Apr 22, 2021
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism.Abdolkarim Mahrooz, Giovanna Muscogiuri, Raffaella Buzzetti
|Oct 06, 2018
Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes.Durdi Qujeq, Abdolkarim Mahrooz, Ahad Alizadeh
Pageof 1
